H. Lundbeck, Cipralex® approvals in Europe

As described in the interim report for the first quarter of 2002, released to the Copenhagen Stock Exchange on 7 May 2002, we hereby issue a complete and final overview of the EEA-countries that have approved Cipralex® for the treatment of depression and anxiety in connection with the Mutual Recognition Procedure.